[go: up one dir, main page]

SG10201608144UA - Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells - Google Patents

Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells

Info

Publication number
SG10201608144UA
SG10201608144UA SG10201608144UA SG10201608144UA SG10201608144UA SG 10201608144U A SG10201608144U A SG 10201608144UA SG 10201608144U A SG10201608144U A SG 10201608144UA SG 10201608144U A SG10201608144U A SG 10201608144UA SG 10201608144U A SG10201608144U A SG 10201608144UA
Authority
SG
Singapore
Prior art keywords
transbiosis
heterochronic
methods
stem cells
pluripotent stem
Prior art date
Application number
SG10201608144UA
Inventor
K Burt Richard
Original Assignee
K Burt Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K Burt Richard filed Critical K Burt Richard
Publication of SG10201608144UA publication Critical patent/SG10201608144UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201608144UA 2015-09-29 2016-09-29 Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells SG10201608144UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562234444P 2015-09-29 2015-09-29

Publications (1)

Publication Number Publication Date
SG10201608144UA true SG10201608144UA (en) 2017-04-27

Family

ID=58523381

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202002971SA SG10202002971SA (en) 2015-09-29 2016-09-29 Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells
SG10201608144UA SG10201608144UA (en) 2015-09-29 2016-09-29 Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202002971SA SG10202002971SA (en) 2015-09-29 2016-09-29 Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells

Country Status (3)

Country Link
US (2) US10813955B2 (en)
BR (1) BR102016022647A2 (en)
SG (2) SG10202002971SA (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10813955B2 (en) 2015-09-29 2020-10-27 Genani Corporation Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
WO1999027076A1 (en) 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP1435977A4 (en) * 2001-09-19 2005-06-08 Ford Henry Health System CARDIAC TRANSPLANTATION OF STEM CELLS FOR THE TREATMENT OF CARDIAC INSUFFICIENCY
ATE397654T1 (en) 2002-02-06 2008-06-15 Stiftung Caesar PLURIPOTENT EMBRYON-LIKE STEM CELLS DERIVED FROM TEETH AND USES THEREOF
ES2422193T3 (en) 2002-06-28 2013-09-09 Life Technologies Corp Methods to restore the immune repertoire in patients with immunological defects related to autoimmunity and transplantation of hematopoietic organs or stem cells
CA2493871A1 (en) 2002-07-16 2004-01-22 Hadi Aslan Methods of implanting mesenchymal stem cells for tissue repair and formation
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
WO2006071802A2 (en) 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
US20070092494A1 (en) 2005-10-26 2007-04-26 Biomet Manufacturing Corp. Composition for wound healing using lyophilized skin or skin-derived collagen
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US20070292401A1 (en) 2006-06-20 2007-12-20 Harmon Alexander M Soft tissue repair and regeneration using stem cell products
MX2009000741A (en) * 2006-07-20 2009-07-17 Richard Burt Method of using mitotically inactivated stem cells for damaged tissue repair.
CN101156944A (en) 2006-10-07 2008-04-09 于廷曦 Cleavage liquid for preventing and curing nervus energy disease scathing nervus stem cell
EP2132299A4 (en) 2007-03-01 2010-03-10 Cryo Cell Int SUPPLY, ISOLATION AND CRYOPRESERVATION OF ENDOMETRIAL / MENSTRUAL CELLS
US20110020291A1 (en) 2007-11-17 2011-01-27 Debrabrata Banerjee Use of stem cells for wound healing
CN101449822A (en) 2007-12-05 2009-06-10 詹承镇 Embryo telomerase food
EP2282746B8 (en) 2008-03-27 2015-12-09 Caladrius Biosciences, Inc. Compositions and methods using stem cells in cutaneous wound healing
US8790638B2 (en) 2009-02-04 2014-07-29 Stemedica Cell Technologies, Inc. Compositions of stem cells and stem cell factors and methods for their use and manufacture
US20120141433A1 (en) 2010-10-06 2012-06-07 Nikolai Tankovich Vaporized Stem Cell Derivatives for Topical and Other Therapeutic Uses
US9364425B2 (en) 2012-03-19 2016-06-14 Richard Burt Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells
US10596202B2 (en) 2012-09-19 2020-03-24 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US9872937B2 (en) 2012-09-19 2018-01-23 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
CN103751228B (en) 2014-01-27 2016-04-20 贵州神奇药物研究院 Medicine for the treatment of senile dementia and preparation method thereof
US10813955B2 (en) 2015-09-29 2020-10-27 Genani Corporation Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells

Also Published As

Publication number Publication date
BR102016022647A2 (en) 2017-04-04
SG10202002971SA (en) 2020-05-28
US10828338B2 (en) 2020-11-10
US20180296610A1 (en) 2018-10-18
US20170106024A1 (en) 2017-04-20
US10813955B2 (en) 2020-10-27

Similar Documents

Publication Publication Date Title
IL248299A0 (en) A method and kit for determining the tissue or cell origin of dna
IL255116A0 (en) Methods of tissue repair and regeneration
GB2536538B (en) Anchor for implantation in body tissue
IL250132A0 (en) Method for inducing t cells for immunocytotheraphy from pluripotent stem cells
EP3334820C0 (en) Induced extended pluripotent stem cells, methods of making and using
IL251576A0 (en) Methods and compositions for generating or maintaining pluripotent cells
EP3364916C0 (en) MEDICAL IMPLANT FOR HEART VALVE REPAIR
PL3145517T3 (en) Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same
GB201609438D0 (en) Compositions and methods for cell targeted HPV treatment
EP3138399A4 (en) Composition for organ, tissue, or cell transplantation, kit, and transplantation method
PT3174563T (en) Tissue graft
EP3234116A4 (en) Methods of treating tissue calcification
PL3586821T3 (en) Stem cell stimulating compositions and methods
IL257678A (en) Methods for stem cell transplantation
SG10201913752PA (en) Methods and compositions for stem cell transplantation
PT3389620T (en) Stem cell stimulating compositions and methods of treating melasma
EP4039226C0 (en) IMPLANTABLE PROSTHESIS FOR SOFT TISSUE REPAIR
GB201805287D0 (en) Haematoietic stem cell treatment
EP3206498A4 (en) Methods for conducting stimulus-response studies with induced pluripotent stem cells derived from perinatal cells or tissues
EP3134096A4 (en) Methods of enhancing stem cell engraftment
SG10202002971SA (en) Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells
ZA201607027B (en) Method for treating or enhancing muscle tissue
GB201506044D0 (en) Methods for determining the effect of an agent on tissue stem cells
GB201414992D0 (en) Resetting human pluripotent stem cells
HUP1400615A2 (en) Laboratory procedure for obtaining mesenchymal stem cells from adipose tissue and for frozen storage